Related Experiment Video
Updated: Apr 19, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Dexamethasone activates transient receptor potential canonical 4 (TRPC4) channels via Rasd1 small GTPase pathway
Jinhong Wie1, Jinsung Kim1,2, Kotdaji Ha1
1Department of Physiology, Seoul National University College of Medicine, Seoul, 110-799, Republic of Korea.
Abstract:
Canonical transient receptor potential 4 (TRPC4) channels are calcium-permeable, nonselective cation channels that are widely distributed in mammalian cells. It is generally speculated that TRPC4 channels are activated by Gq/11-PLC pathway or directly activated by Gi/o proteins. Although many mechanistic studies regarding TRPC4 have dealt with heterotrimeric G proteins, here, we first report the functional relationship between TRPC4 and small GTPase, Rasd1. Rasd1 selectively activated TRPC4 channels, and it was the only Ras protein among Ras protein family that can activate TRPC4 channels. For this to occur, it was found that certain population of functional Gαi1 and Gαi3 proteins are essential. Meanwhile, dexamethasone, a synthetic glucocorticoid and anti-inflammatory drug was known to increase messenger RNA (mRNA) level of Rasd1 in pancreatic β-cells. We have found that dexamethasone triggers TRPC4-like cationic current in INS-1 cells via increasing protein expression level of Rasd1. This relationship among dexamethasone, Rasd1, and TRPC4 could suggest a new therapeutic agent for hospitalized diabetes mellitus (DM) patients with prolonged dexamethasone prescription.
Insights
The study reveals Rasd1 selectively activates TRPC4 channels, a novel finding. Dexamethasone increases Rasd1, triggering TRPC4 currents, suggesting potential diabetes mellitus therapies.
Area of Science:
- Molecular Biology
- Cell Physiology
- Pharmacology
Background:
- Canonical transient receptor potential 4 (TRPC4) channels are calcium-permeable cation channels found in mammalian cells.
- TRPC4 channel activation is typically linked to Gq/11-PLC or Gi/o protein pathways.
- Previous research focused on heterotrimeric G proteins, leaving the role of small GTPases unexplored.
Purpose of the Study:
- To investigate the functional relationship between TRPC4 channels and the small GTPase Rasd1.
- To determine if Rasd1 selectively activates TRPC4 channels and identify necessary co-factors.
- To explore the effect of dexamethasone on TRPC4 channel activity in pancreatic beta-cells.
Main Methods:
- Investigated the interaction between Rasd1 and TRPC4 channels using cell-based assays.
- Examined the role of Gαi1 and Gαi3 proteins in Rasd1-mediated TRPC4 activation.
- Assessed the impact of dexamethasone on Rasd1 protein expression and TRPC4-like currents in INS-1 cells.
Main Results:
- Rasd1 was identified as a novel and selective activator of TRPC4 channels among Ras proteins.
- Functional Gαi1 and Gαi3 proteins were found to be essential for Rasd1-mediated TRPC4 channel activation.
- Dexamethasone treatment increased Rasd1 protein levels and induced TRPC4-like cationic currents in INS-1 cells.
Conclusions:
- Rasd1 represents a new class of TRPC4 channel activators.
- The dexamethasone-Rasd1-TRPC4 pathway offers a potential therapeutic target for managing diabetes mellitus in patients on prolonged dexamethasone therapy.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
MAPK Signaling Cascades
GPCRs Regulate Adenylyl Cylase Activity
IP3/DAG Signaling Pathway
Activation and Inactivation of G Proteins
GPCR Desensitization

